دورية أكاديمية
Antibiotic Prescribing Practices for Treating COVID-19 Patients in Bangladesh
| العنوان: | Antibiotic Prescribing Practices for Treating COVID-19 Patients in Bangladesh |
|---|---|
| المؤلفون: | Utpal Kumar Mondal, Tahmidul Haque, Md Abdullah Al Jubayer Biswas, Syed Moinuddin Satter, Md Saiful Islam, Zahidul Alam, Mohammad Shojon, Shubroto Debnath, Mohaiminul Islam, Haroon Bin Murshid, Md Zakiul Hassan, Nusrat Homaira |
| المصدر: | Antibiotics, Vol 11, Iss 10, p 1350 (2022) |
| بيانات النشر: | MDPI AG, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | COVID-19, antimicrobial resistance, antibiotics, treatment, physicians, Bangladesh, Therapeutics. Pharmacology, RM1-950 |
| الوصف: | Although national and international guidelines have strongly discouraged use of antibiotics to treat COVID-19 patients with mild or moderate symptoms, antibiotics are frequently being used. This study aimed to determine antibiotics-prescribing practices among Bangladeshi physicians in treating COVID-19 patients. We conducted a cross-sectional survey among physicians involved in treating COVID-19 patients. During September–November 2021, data were collected from 511 respondents through an online Google Form and hardcopies of self-administered questionnaires. We used descriptive statistics and a regression model to identify the prevalence of prescribing antibiotics among physicians and associated factors influencing their decision making. Out of 511 enrolled physicians, 94.13% prescribed antibiotics to COVID-19 patients irrespective of disease severity. All physicians working in COVID-19–dedicated hospitals and 87% for those working in outpatient wards used antibiotics to treat COVID-19 patients. The majority (90%) of physicians reported that antibiotics should be given to COVID-19 patients with underlying respiratory conditions. The most prescribed antibiotics were meropenem, moxifloxacin, and azithromycin. Our study demonstrated high use of antibiotics for treatment of COVID-19 patients irrespective of disease severity and the duty ward of study physicians. Evidence-based interventions to promote judicious use of antibiotics for treating COVID-19 patients in Bangladesh may help in reducing an overuse of antibiotics. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 11101350 2079-6382 |
| Relation: | https://www.mdpi.com/2079-6382/11/10/1350; https://doaj.org/toc/2079-6382 |
| DOI: | 10.3390/antibiotics11101350 |
| URL الوصول: | https://doaj.org/article/f16b714e02e14b44bf13fcd9da260bb0 |
| رقم الأكسشن: | edsdoj.f16b714e02e14b44bf13fcd9da260bb0 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 11101350 20796382 |
|---|---|
| DOI: | 10.3390/antibiotics11101350 |